STAT
MARCH 3, 2023
The American College of Surgeons recently announced its new well-being initiative for surgeons. This wellness program has lofty goals: [The ACS] recognizes the need to foster well-being, resilience, and work-life integration for all surgeons, regardless of their career stage. Fostering the growth of both the surgical expertise and the person as a whole is paramount.
Drug Topics
MARCH 3, 2023
Your weekly roundup of the latest news from Drug Topics®.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
MARCH 3, 2023
Walgreens won't sell abortion pills in GOP states after legal threats from state officials agliadkovskaya Fri, 03/03/2023 - 17:18
Drug Store News
MARCH 3, 2023
Lilly also will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MARCH 3, 2023
You’d think an irradiated wasteland would be a poor place to make a home, but some animals beg to differ. Since the Chernobyl nuclear meltdown 37 years ago, both wild animals and free-roaming domesticated dogs have, to the surprise and delight of environmentalists, flocked to and flourished in the evacuated,1,000 square mile zone surrounding the plant.
Fierce Healthcare
MARCH 3, 2023
Physicians are twice as likely as the general population to attempt suicide, Medscape survey finds aburky Fri, 03/03/2023 - 14:54
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
DiversifyRx
MARCH 3, 2023
What You Need to Know Before You Open a Pharmacy The pharmacy industry is a complex one. Likewise, opening a pharmacy can be complicated. In order to succeed, you need to be a master of both medicine and commerce. This is a guest post blog from our friends at PioneerRx. There isn’t a clear roadmap to go from pharmacist to pharmacy owner, but there are several things you should think about in order to make the transition smoother.
STAT
MARCH 3, 2023
Next week, hundreds of scientists from around the world will convene in London for an international summit on genome editing. That technology, which enables scientists to easily excise, alter, or replace specific sections of DNA, was awarded the 2020 Nobel Prize for Chemistry. But the last time an event like this took place, in November 2018, carefully planned discussions about how it might be responsibly harnessed to treat genetic diseases were derailed by news that a team of researchers in Chi
ISPE
MARCH 3, 2023
ISPE Europe Annual Conference, 8th to 10th May 2023 - What You Need to Know about the GAMP® Track! Trudy Patterson Fri, 03/03/2023 - 13:15 iSpeak Blog iSpeak ISPE Europe Annual Conference, 8th to 10th May 2023 - What You Need to Know about the GAMP® Track! Frank Henrichmann Heather D. Watson Elena Vulpe 3 March 2023 GAMP ® 5 (Second Edition) was published on 29th July 2022 and was presented and discussed at the 2023 ISPE Annual Meeting and at several local GAMP ® events held around the globe.
STAT
MARCH 3, 2023
“But aren’t you grateful to be alive”? That’s a question adoptees like me are often asked when we speak out against the Supreme Court’s decision to overturn Roe v. Wade. Like other adoptees, I hesitate to answer, feeling the pressure to respond as we’ve been trained to by society, “Yes, I’m grateful, so very grateful.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Topics
MARCH 3, 2023
Convatec’s InnovaBurn is the first product of its kind intended to help patients manage burns and wounds.
STAT
MARCH 3, 2023
Just over two weeks ago, President Biden had skin cancer, but today, he doesn’t. According to a White House physician’s memo on Friday, doctors at Walter Reed National Military Medical Center removed a lesion off his chest on Feb. 16, treated the area around the tumor site, and that was that. The president’s cancer might be cause for more concern were it not for the type: basal cell carcinoma.
Drug Topics
MARCH 3, 2023
Artificial intelligence has many applications in health care, but hurdles to widespread adoption remain.
STAT
MARCH 3, 2023
WASHINGTON — A new approach to paying doctors and hospitals — originally billed as a way to bolster traditional Medicare — might be speeding the public health insurance program’s privatization. Medicare Advantage typically gets credited, or blamed, for moving beneficiaries into a system run by private health insurers. The program has grown rapidly since its inception ; nearly half of people on Medicare are now in a private plan.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
MARCH 3, 2023
Black adults more likely to seek mental health treatment at EDs, pre-pandemic data show dmuoio Fri, 03/03/2023 - 11:36
STAT
MARCH 3, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is a decidedly low-key affair. We look forward to promenading with the official mascot, binge-watching in front of the telly, and holding our weekly listening party (the rotation includes this , this and this ).
Drug Topics
MARCH 3, 2023
Community pharmacists can provide crucial services that meet patients where they are: at home.
STAT
MARCH 3, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Pharmafile
MARCH 3, 2023
Scientists from the Institute of Cancer Research London, Imperial College London and the Netherlands Cancer Institute have researched a gene test which can select which advanced bowel cancer patients will respond the best to chemotherapy. Their findings, published in Nature Medicine , describe how patients without mutations in the KRAS gene (wildtype) may benefit from trifluridine/tipiracil chemotherapy: a last-line treatment for patients whose cancer has not responded to anything else.
STAT
MARCH 3, 2023
File this under: “What were they thinking?” Cipla, which is one of the world’s largest generic drug manufacturers, was recently cited by inspectors from the U.S. Food and Drug Administration for a litany of violations at a plant in India. But one problem stood out: the company failed to properly keep important manufacturing records and, instead had loaded bags paper scraps onto a truck and stored other bags that were earmarked for shredding.
Fierce Pharma
MARCH 3, 2023
Sanders urges Sanofi, Novo Nordisk to be like Eli Lilly in reducing insulin prices kdunleavy Fri, 03/03/2023 - 10:38
Drug Store News
MARCH 3, 2023
The company went bankrupt in 2020 after a $4.3 billion takeover offer failed, according to a Bloomberg Law report that cited court documents.
European Pharmaceutical Review
MARCH 3, 2023
The UK government has confirmed its plans to go ahead with the intended Statutory Scheme rate rise. This means the revenue clawback rate paid by pharmaceutical companies subject to the Statutory Scheme for branded medicines will increase from 24.4 percent to 27.5 percent. The Association of the British Pharmaceutical Industry (ABPI) and Lilly and Company have responded, emphasising the plans are not supportive to life sciences sector.
Drug Store News
MARCH 3, 2023
Shoppers can donate at checkout by rounding up their total to the nearest dollar or by donating $1, $3 or $5, the company said.
Drug Topics
MARCH 3, 2023
Help your independent pharmacy stand out in a world of retail chains.
Drug Store News
MARCH 3, 2023
The Advanced Care Face + Body Cleansing collection is formulated to help solve men’s top skin concerns—beginning in the shower.
Pharmafile
MARCH 3, 2023
The FDA has reportedly rejected a bid by Elon Musk’s Neuralink in which they proposed the initiation of human testing for its brain chip implants. The company have been working on brain implants that allow for a computer-brain interface, which could allegedly restore vision to the blind and help paralysed people to walk again.
Drug Store News
MARCH 3, 2023
The brand refresh includes three new scent variants and features on-trend ingredients to spark senses and the skin, the company said.
European Pharmaceutical Review
MARCH 3, 2023
A new Excipients Strategy (EXS) Working Party has been created by the European Pharmacopoeia Commission (EPC). The group will continue to address the specificities of excipients in European Pharmacopoeia (Ph. Eur.) monographs and reflect on how best to further develop the Ph. Eur. strategy. During its 173rd session in June 2022, the EPC decided to refine the strategy for excipient monographs in the Ph.
Drug Store News
MARCH 3, 2023
HealthInHand.org aims to empower people to take greater control over self-care.
Pharmafile
MARCH 3, 2023
The FDA has granted Temferon an Orphan Drug Designation (ODD) for use as a therapeutic option for patients with glioblastoma multiforme, says clinical-stage immune-oncology company Genenta Science in an announcement. The safety and efficacy of the drug is being evaluated in the phase 1/2 TEM-GBM trial, which includes up to 21 patients with newly diagnosed glioblastoma with an unmethylated MGMT promoter.
Fierce Healthcare
MARCH 3, 2023
Healthcare Dealmakers—CVS buys Oak Street Health for $10.6B; Amazon closes $3.
Fierce Pharma
MARCH 3, 2023
After AbbVie and Lilly exited UK pricing scheme, Viatris weighs similar move: report zbecker Fri, 03/03/2023 - 11:23
Pharmaceutical Technology
MARCH 3, 2023
Bristol Myers Squibb has secured complete marketing authorisation from the European Commission (EC) for Reblozyl (luspatercept) to treat anaemia in adult patients with non-transfusion dependent (NTD) beta-thalassemia. The regulatory approval enables the use of Reblozyl in all EU member states, as well as Liechtenstein, Iceland, and Norway. The first-in-class therapeutic option, Reblozyl is being developed and commercialised through an international partnership with Merck after the acquisition of
Expert insights. Personalized for you.
145 
Let's personalize your content